| Overview |
| bsm-90072r-50µL |
| CD36 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human CD36 |
| 350-400/472 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 948 |
| P16671 |
| CD36; CD36 Molecule; GPIIIB; GPIV; GP3B; FAT; GP4; Platelet Glycoprotein 4; Fatty Acid Translocase; SCARB3; CD36 Antigen (Collagen Type I Receptor Thrombospondin Receptor); CD36 Molecule (Thrombospondin Receptor); Leukocyte Differentiation Antigen CD36; Platelet Glycoprotein IV; Glycoprotein IIIb; PAS IV; Scavenger Receptor Class B Member 3; Scavenger Receptor Class B Member 3; Platelet Collagen Receptor; Thrombospondin Receptor; Cluster Determinant 36; PAS-4 Protein; CD36 Antigen; BDPLT10; CHDS7; PASIV; PAS-4 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |